In:
Alzheimer's & Dementia, Wiley, Vol. 14, No. 3 ( 2018-03), p. 293-305
Abstract:
Impact of amyloid positron emission tomography (PET) on diagnosis and management in a naturalistic setting. Patients with complex clinical situations in absence of conclusive cerebrospinal fluid results. Highly selected patient population and hierarchical positioning of Alzheimer's disease biomarkers. Use of amyloid PET without interfering with the clinical standard practices. Immediate benefit of amyloid PET in the most complex situations in current practice.
Type of Medium:
Online Resource
ISSN:
1552-5260
,
1552-5279
DOI:
10.1016/j.jalz.2017.09.009
Language:
English
Publisher:
Wiley
Publication Date:
2018
detail.hit.zdb_id:
2201940-6
